DAVID R GUYER Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID R GUYER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID R GUYER. DAVID R GUYER is an CHIEF EXECUTIVE OFFICER in EYETECH PHARMACEUTICALS INC ($EYET) and a in EyePoint Pharmaceuticals, Inc. ($EYPT) and an Chief Executive Officer in Ophthotech Corp. ($OPHT) and an Executive Chairman in Ophthotech Corp. ($OPHT).
Address: C/O EYETECH PHARMACEUTICALS, INC. 500 SEVENTH AVENUE, 18TH FLOOR NEW YORK 10018 NY
Companies in which DAVID R GUYER is an Insider
EyePoint Pharmaceuticals, Inc.
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of DAVID R GUYER:
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 29 2019
$EYPT Market Capitalization: $60.15M
$EYPT Previous Close: $1.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
EYETECH PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID R GUYER: CHIEF EXECUTIVE OFFICER
Holdings: 0 shares
Latest Transaction: Feb 23 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IVERIC bio, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID R GUYER: Executive Chairman, Chief Executive Officer
Holdings: 79,383 shares
Current Value: $351,667
Latest Transaction: Dec 22 2020
$OPHT Market Capitalization: $156.71M
$OPHT Previous Close: $4.43
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of DAVID R GUYER
Sentiment: All, EYPT, EYET, OPHT
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 22 2020 | OPHT | IVERIC bio, Inc. | GUYER DAVID R | Executive Chairman | Option Exercise | A | 0.00 | 102,630 | 0 | 102,630 | |
| Dec 22 2020 | OPHT | IVERIC bio, Inc. | GUYER DAVID R | Executive Chairman | Option Exercise | A | 7.50 | 205,150 | 1,538,625 | 205,150 | |
| Dec 15 2020 | OPHT | IVERIC bio, Inc. | GUYER DAVID R | Executive Chairman | Option Exercise | M | 0.00 | 17,200 | 0 | 34,400 | |
| Dec 15 2020 | OPHT | IVERIC bio, Inc. | GUYER DAVID R | Executive Chairman | Sell | S | 7.16 | 9,270 | 66,373 | 70,113 | 79.4 K to 70.1 K (-11.68 %) |
| Dec 15 2020 | OPHT | IVERIC bio, Inc. | GUYER DAVID R | Executive Chairman | Buy | M | 0.00 | 17,200 | 0 | 79,383 | 62.2 K to 79.4 K (+27.66 %) |
| Dec 11 2020 | OPHT | IVERIC bio, Inc. | GUYER DAVID R | Executive Chairman | Option Exercise | A | 0.00 | 17,813 | 0 | 53,437 | |
| Dec 11 2020 | OPHT | IVERIC bio, Inc. | GUYER DAVID R | Executive Chairman | Sell | S | 6.96 | 9,602 | 66,830 | 62,183 | 71.8 K to 62.2 K (-13.38 %) |